| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | — | — |
| Gross Profit | — | — |
| EBITDA | — | — |
| Net Income | €594.0M | +102.7% |
| Diluted EPS | €27.80 | +102.9% |
| Free Cash Flow | — | — |
| DPS (FY2022) | €5.58 |
| Trailing yield | 7.39% |
| Payout ratio | — |
| Growth streak | 0 yrs |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20222022-12-31 | €5.58 | — | reported |
| FY20212021-12-31 | — | — | reported |
| FY20202020-12-31 | — | — | reported |
| Ratio | 2020 | 2021 | 2022 | Trend · 3y | vs own |
|---|---|---|---|---|---|
| ▾Returns on Capital | |||||
| Return on Equity | — | 10.90% | 18.46% | 75% | |
| Return on Assets | — | — | 17.29% | — | 50% |
| ▸DuPont factors (ROE drivers) · 1 ratios | |||||
| ▸Earnings quality · 2 ratios | |||||
| ▸Liquidity & coverage · 2 ratios | |||||
| ▸Leverage · 6 ratios | |||||
| ▸Capital allocation · 3 ratios | |||||
| Line | 2020 | 2021 | 2022 |
|---|---|---|---|
| Total Operating Expenses | €4.0M | €2.0M | €2.0M |
| YoY % | -50.0% | 0.0% | |
| Interest Expense | €4.0M | €3.0M | €3.0M |
| YoY % | -25.0% | 0.0% | |
| Equity Method Income | -€304.0M | €298.0M | €599.0M |
| YoY % | +101.0% | ||
| Net Income (incl. NCI) | -€312.0M | €293.0M | €594.0M |
| YoY % | +102.7% | ||
| EPS (Basic) | — | €13.70 | €27.80 |
| YoY % | +102.9% | ||
| EPS (Diluted) | — | €13.70 | €27.80 |
| YoY % | +102.9% | ||
| Dividends Declared per Share | — | — | €6 |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
